Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Equity (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Return on Equity for 6 consecutive years, with 1.12% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 50.0% to 1.12% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.12% through Dec 2025, down 50.0% year-over-year, with the annual reading at 0.79% for FY2025, 31.0% down from the prior year.
  • Return on Equity for Q4 2025 was 1.12% at Caribou Biosciences, down from 1.03% in the prior quarter.
  • The five-year high for Return on Equity was 1.27% in Q1 2021, with the low at 1.12% in Q4 2025.
  • Average Return on Equity over 5 years is 0.31%, with a median of 0.36% recorded in 2021.
  • The sharpest move saw Return on Equity tumbled -215bps in 2021, then increased 7bps in 2022.
  • Over 5 years, Return on Equity stood at 0.17% in 2021, then tumbled by -102bps to 0.34% in 2022, then rose by 11bps to 0.3% in 2023, then plummeted by -106bps to 0.62% in 2024, then crashed by -80bps to 1.12% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.12%, 1.03%, and 0.87% for Q4 2025, Q3 2025, and Q2 2025 respectively.